What You Should Know:
- The research is mounting to show that Anumana’s AI-ECG algorithms could dramatically improve screening for cardiovascular disease (CVD), providing early warnings of disease from just a standard electrocardiogram (ECG). Yesterday, a study was published in Nature Medicine that shows an Anumana AI algorithm applied to Apple Watch ECG recordings successfully identified a weak heart pump in patients.
- This follows other recent research findings, published in The
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
How Continuous Glucose Monitoring Can Alleviate Language Barriers in Diabetes Care
As an endocrinologist with 19 years of experience in treating patients with diabetes, one of the most important lessons I’ve learned is that communication is key.
Patients with diabetes live with the heavy burden of making choices and taking action every single day to manage their blood glucose levels. Thankfully, advancements in technology have come incredibly far, giving way to tools like continuous glucose monitors (CGM), automated insulin delivery systems and more. But for
Read More
How Virtual-First Clinical Trials Scale Access for Participants
Making clinical trials equitable is one of the biggest challenges we face as an industry. We see this time and again, with one of the latest examples coming in the form of a study published in JAMA Network Open that found substantial underrepresentation of Black patients enrolled in pivotal trials for CAR-T therapy.
Women are another demographic negatively affected by inequality in clinical research. Earlier this month [May 2022] the American Heart Association issued a
Read More
Hims & Hers Appoints Dr. Knoer as First-Ever Chief Pharmacy & Innovation Officer
What You Should Know:
- Hims & Hers Health, Inc. appoints pharmacy industry veteran Dr. Scott Knoer, Pharm.D., MS, FASHP, as the company’s first-ever Chief Pharmacy & Innovation Officer.
- As Chief Pharmacy & Innovation Officer, Dr. Knoer will oversee pharmacy strategy and innovation efforts for Hims & Hers. Knoer will direct efforts to develop proprietary formulations that will make it possible to provide customers with personalized health and wellness advancements. Hims
Read More
Intel Labs & Penn Medicine Uses Privacy-Preserving AI to Identify Brain Tumors
What You Should Know:
- Intel Labs and the Perelman School of Medicine at the University of Pennsylvania (Penn Medicine) have completed a joint research study using federated learning – a distributed machine learning (ML) artificial intelligence (AI) approach – to help international healthcare and research institutions identify malignant brain tumors.
- The largest medical federated learning study to date with an unprecedented global dataset examined from 71 institutions across six
Read More
Digital Health VCs Cite ROI & Clinical Validation As Greatest Markers of Company’s Success
What You Should Know:
- Investors in the healthcare technology space believe a measurable return on investment (ROI) and clinical validation of the technology's platform will be the greatest indicators of company success in 2023, according to a new survey of top digital health investors by GSR Ventures.
- ROI was deemed "important" or "very important" to the success of digital health companies by more than 94% of investor respondents, and 79% for clinical evidence and trials.
Top
Read More
AI Improving the Patient Experience of Cancer Care
For cancer patients and their loved ones, days, weeks, and months matter. In fact, anyone who has waited anxiously for test results or a treatment regimen to begin can attest that hours, or even minutes, will drag on with emotional heaviness. From a clinical standpoint as well, time to treatment significantly impacts outcomes. All suspected cancers should be ruled out or confirmed with a diagnosis so treatment can begin as soon as possible. Similarly, patients with incidental findings—masses or
Read More
Why Preventive Healthcare Hinges on Diagnostics Innovation
There is a real sense that we are on the cusp of a diagnostics revolution. This has been spurred on by the pandemic, which at once underscored the tremendous power of mass testing as it became the fundamental basis for decision-making, from our own personal health to national policy. It also revealed gaps in terms of needing to drastically scale up testing capacity and invest in new and innovative digital diagnostics tools.
Innovation in diagnostics, however, is
Read More
Elevance Health Launches AI-Driven Nutrition Tracker
What You Should Know:
- Elevance Health -- formerly Anthem, Inc. has announced the expansion of its Sydney Health application with the addition of a nutrition tracker function driven by artificial intelligence (AI). The new feature, called Nutrition Tracker, recognizes foods or an entire meal, providing virtual nutrition advice to improve affiliated health plan members’ overall health and well-being.
- Using smartphone cameras and typing-free nutrition tracking, affiliated health plan
Read More
PE Firms Rebrand Prison Healthcare Companies, But Care Issues Continue
What You Should Know:
- A new report, “Private Equity Firms Rebrand Prison Healthcare Companies, But Care Issues Continue,” by the Private Equity Stakeholder Project (PESP) focuses on healthcare company Wellpath and the regulatory risks that the company continues to take in local jails and prisons.
- Wellpath is owned by private equity firm H.I.G. Capital and is among the largest healthcare companies serving U.S. prisons and jails. Wellpath has had a litany of staffing and access to
Read More
